Dose-finding trials of antibody-based drugs for HIV prevention will start soon
Long-acting injectable cabotegravir + rilpivirine works well as HIV maintenance therapy
Early antiretroviral therapy has no impact on marker of early cardiovascular disease
Women and African Americans with HIV have a higher risk of stroke
Tenofovir treatment raises the risk of broken bones
Vaginal rings containing antiretroviral moderately effective in preventing HIV – but not in the youngest women
